Literature DB >> 509224

Effect of thiamine deficiency on brain serotonin turnover.

M H Van Woert, A Plaitakis, E C Hwang, S Berl.   

Abstract

Serotonin turnover has been investigated in regional brain areas of rats made thiamine deficient by pyrithiamine (PT). Following intracisternal injection of [14C]5-hydroxytryptamine ([14C]5-HT), a marked increase in the accumulation of [14C]5-hydroxyindoleacetic acid ([14C]5-HIAA) was found in the medulla-pons, hypothalamus and cerebral cortex. [14C]5-HT levels were normal in all of the brain areas except the cerebral cortex which had an increase of 58%. The ratio of [14C]5-HIAA/[14C]5-HT was significantly increased in every brain region of PT-treated rats except the cerebral cortex. Part of this increase in [14C]5-HIAA was shown to be due to impairment of active transport of this 5-HT metabolite out of the brain. However, increased 5-HT synthesis in the cerebellum, hypothalamus, striatum, hippocampus and cerebral cortex was demonstrated by measurement of 5-HT accumulation after inhibition of brain monoamine oxidase. PT-induced increase in endogenous 5-HIAA in the medulla-pons occurred simultaneously with the onset of neurological signs and both parameters were reversible by thiamine administration. These results suggest that acute thiamine deficiency, induced by PT, both increases brain 5-HT synthesis and impairs 5-HIAA efflux from the brain. There is a close correlation between neurological manifestations and changes in brain 5-HT metabolism in acute thiamine deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509224     DOI: 10.1016/0006-8993(79)90494-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

Review 2.  Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome.

Authors:  Ryan P Vetreno; Raddy L Ramos; Steven Anzalone; Lisa M Savage
Journal:  Brain Res       Date:  2011-11-28       Impact factor: 3.252

3.  Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.

Authors:  G P Rice; J Lesaux; P Vandervoort; L Macewan; G C Ebers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 4.  From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists.

Authors:  Gohar Fakhfouri; Kazem Mousavizadeh; Sharam Ejtemaei Mehr; Ahmad Reza Dehpour; Mohammad Reza Zirak; Jean-Eric Ghia; Reza Rahimian
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

Review 5.  Serotonin, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  GABA-transaminase and glutamic acid decarboxylase changes in the brain of rats treated with pyrithiamine.

Authors:  S G Thompson; E G McGeer
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

7.  Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats.

Authors:  P J Langlais; R G Mair; C D Anderson; W J McEntee
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.